Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*

PaperCitations, authors & open-access status

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)* is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 247 citations, 2019 year and green oa status.

247
Citations
2019
Year
green
OA Status

Related on ScholarIQ

Elliott D. Crouser
Author
Critical Care Medicine
Journal
Sepsis Diagnosis and Treatment
Topic
Sepsis Diagnosis and Treatment
Topic
Cancer Immunotherapy and Biomarkers
Topic
Acute Kidney Injury Research
Topic
470M+ articles · free account